ROBERT BURKE: Open Payments
NPI 1629044987 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 27 payments from 18 companies in 2025. Trend: 2023 $1,342 · 2024 $632 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $107 |
| PFIZER INC. | 4 | $65 |
| Lilly USA, LLC | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Indivior Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
Products named: REXULTI, MOUNJARO, PREVNAR 20, SHINGRIX, SUBLOCADE, BREZTRI, Wegovy, SPRAVATO.
Industry payments across NY — which companies pay providers there.
